South & Central America Enteral Medical Nutrition Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Indication (Respiratory Disorders, Cancer, Post COVID-19, Gastrointestinal Disorders, Liver Failure, and Others), Nutrition Type (Supple

South & Central America Enteral Medical Nutrition Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Indication (Respiratory Disorders, Cancer, Post COVID-19, Gastrointestinal Disorders, Liver Failure, and Others), Nutrition Type (Supplemental and Sole-Source), Form (Powder, Liquid, and Semi-Solid), Product (Standard Protein Diet, High Protein Diet, Fruit Juice Based Oral Nutritional Supplement, and Others), Distribution Channel (Hospital Pharmacies, Retail Stores, and Others), and Age Group [Child (Till 18 Years) and Adults (18+years)]

The enteral medical nutrition market in South & Central America is expected to grow from US$ 435.35 million in 2022 to US$ 625.02 million by 2028. It is estimated to grow at a CAGR of 6.2% from 2022 to 2028.

Use of Next Generation Technology for Proper Enteral Nutrition Feeding

In enteral feeding, it is important to calculate patient’s daily and cumulative energy balance, as it helps doctor plan the feeding routing according to the need of patient and decrease the morbidity and mortality risk among the patients. It is also essential to maintain the nutrient supply after discharge. There is no proper technology or equipment available for calculating the patient’s daily and cumulative energy balance. Researchers are now focusing on the use of artificial intelligence (AI) and prediction algorithms for the development of technology that can be used to handle caloric and protein deficit and monitor the energy balance. The next generation technology for enteral nutrition feeding can be used to create communication between ICU and post-ICU discharge units to understand the nutrition regime and predictive deficit. Hospital food left uneaten by patients can be analyzed to evaluate the energy, and protein and vitamins deficits. Similar approach could overcome the deficits in the post ICU period. The implementation of next generation technology-based tools in the critical stage could help to ensure that a patient's nutritional plan and goals are constantly measured, monitored, and achieved. In addition, wearable data could be integrated with Electronic Health Record (EHR) data, including data from sensors continuously measuring physical activity and glucose level. The growing fields of metabolomics and proteomics hold the potential to assess nutritional status, set appropriate adjustments of the nutrient mix, and monitor progress through various stages of illness. Therefore, the use of AI, prediction analytics, metabolomics and proteomics, and many next generation technologies in enteral medical nutrition for proper feeding routine is expected to create lucrative growth opportunities for the enteral medical nutrition market during the forecast period.

Market Overview



SAM enteral medical nutrition market includes Brazil, Argentina, and Rest of SAM. The region held smallest portion of the market in the global analysis. The market for enteral medical nutrition in the region is expected to have growth opportunities during the forecast period. The enteral medical nutrition market in the SAM region is expected to grow owing to factors such as, an increase in cases of neurological diseases in the region, increasing awareness, and rising healthcare expenditure by the countries of the region.

The increasing prevalence of chronic diseases, such as cancer and diabetes, drives the growth of the enteral medical nutrition market in Brazil. The average prevalence of diabetes in Brazil is 8.0% and is expected to reach 9.8% by 2035. This rising diabetes prevalence has translated into a 60% growth in the related risk ratio for cardiovascular diseases associated with diabetes. This is likely to increase the demand for enteral nutrition in the treatment of the patients.

In addition, the prevalence of neurological disorders has been linked with the aging population in Brazil. The World Health Organization and the Brazilian Institute of Geography and Statistics reported that the geriatric population in Brazil (aged ≥ 60 years) will reach ~55 million by 2040. The rising number of geriatric population is expected to increase the incidence of chronic neurological disorders in the coming years and this increase in the neurological diseases will propel the demand for enteral medical nutrition.

South & Central America Enteral Medical Nutrition Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Enteral Medical Nutrition Market Segmentation

The South & Central America enteral medical nutrition market is segmented into indication, nutrition type, form, product, distribution channel, age group and country.

Based on indication, the South & Central America enteral medical nutrition market is segmented into respiratory disorders, cancer, post COVID-19, gastrointestinal disorders, liver failure, and others. The respiratory disorders segment is expected to hold the largest share in 2022. Based on nutrition type, the South & Central America enteral medical nutrition market is segmented into supplemental and sole source. The supplemental segment is expected to hold the largest share of the market in 2022. Based on form, the South & Central America enteral medical nutrition market is segmented into powder, liquid, and semi-solid. The semi-solid segment is expected to hold the largest share of the market in 2022. Based on product, the South & Central America enteral medical nutrition market is segmented into standard protein diet, high protein diet, fruit juice based oral nutrition, and others. The standard protein diet segment is expected to hold largest share of the market in 2022. Based on distribution channel, the South & Central America Enteral Medical Nutrition market is segmented into Hospital Pharmacies, Retail Stores and Other Pharmacies. The Hospital pharmacies segment is expected to hold the largest share of the market in 2022. Based on Age Group, the South & Central America enteral medical nutrition market is segmented into child (till 18 years) and adults (above 18 years). The adult segment is expected to hold largest share of the market in 2022. Based on country, the market is segmented into Brazil, Argentina, and the Rest of South & Central America is expected to hold the largest market share in 2022. Abbott Laboratories; B. Braun MelsungenAG; DSMNutritional Products AG; Fresenius Kabi AG; Global Health Products, Inc.; Hormel Foods Corporation; Meiji Holdings Co., Ltd.; Nestlé S.A.; Nutricia; and Smartfish AS are the leading companies operating in the enteral medical nutrition market in the region.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South & Central America enteral medical nutrition market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the South & Central America enteral medical nutrition market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the enteral medical nutrition market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution